Buates, Ramir .

HRN: 26-00-13  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/12/2024
CEFTRIAXONE 1G (VIAL)
10/12/2024
10/19/2024
IV
2g
OD
T/c Lymphoma
Waiting Final Action 
10/19/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/19/2024
10/25/2024
IV
4.5 Gm
Q8
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: